974TiP Exploratory phase Ib/IIa study of intratumorally administered tigilanol tiglate to assess safety, tolerability and tumour response in patients with head and neck squamous cell carcinoma

Autor: Gallagher, R.M., Pattatheyil, A., Pantvaidya, G.H., Panizza, B.J., Sharan, R., Deshmukh, A.D., Barnett, C.M.E., Swart, D.J., Mynott, T.L., Cleal, A., Gordon, V., Prawira, A.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S684-S684
Databáze: ScienceDirect